J. Zhu , O.B. Chan , K. Phan , L. Ly , A. Ciconte , J. Su, A Yazdabadi, , M. Sivasaththivel2
In the past three decades, there has been enhanced aware- ness of the prevalence and risk factors associated with hidradenitis suppurativa (HS). This is reﬂected in the growing number of review articles and clinica l studies on HS, which has contributed to elucidating the pathogenesis and the development of biologics in treating this debilitat- ing disease. We bring to light these developments in HS by identifying and analysing the top 100 cited HS articles pub- lished in the past 30 years.
A non-interventional-prospective-12-month study to characterise REAL-life effectiveness and treatmentpatterns of secukinumab, and current standard-of-care of chronic plaque psoriasis in Asia-Pacific & MiddleEast